These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26704785)

  • 1. Trends in the use and impact of neoadjuvant chemotherapy on perioperative outcomes for resected gastric cancer: Evidence from the American College of Surgeons National Cancer Database.
    Greenleaf EK; Hollenbeak CS; Wong J
    Surgery; 2016 Apr; 159(4):1099-112. PubMed ID: 26704785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive surgery for gastric cancer: the American experience.
    Greenleaf EK; Sun SX; Hollenbeak CS; Wong J
    Gastric Cancer; 2017 Mar; 20(2):368-378. PubMed ID: 26961133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
    Kosaka T; Akiyama H; Makino H; Kimura J; Takagawa R; Ono HA; Kunisaki C; Endo I
    Anticancer Res; 2016 Apr; 36(4):1773-7. PubMed ID: 27069158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
    Hermans TJN; Fransen van de Putte EE; Horenblas S; Lemmens V; Aben K; van der Heijden MS; Beerepoot LV; Verhoeven RH; van Rhijn BWG
    Eur J Cancer; 2016 Feb; 54():18-26. PubMed ID: 26707593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
    Kim SH; Seo HK; Shin HC; Chang SJ; Yun S; Joo J; Ku JH; Kim HS; Jeon HG; Jeong BC; Jeong IG; Kang SH; Hong B;
    J Korean Med Sci; 2015 Aug; 30(8):1150-6. PubMed ID: 26240494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in utilization of neoadjuvant therapy and short-term outcomes in resected pancreatic cancer.
    Mirkin KA; Hollenbeak CS; Gusani NJ; Wong J
    Am J Surg; 2017 Jul; 214(1):80-88. PubMed ID: 27816199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.
    Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR
    J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
    Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
    Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
    Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity after Gastrectomy for Gastric Cancer.
    Téoule P; Trojan J; Bechstein W; Woeste G
    Dig Surg; 2015; 32(4):229-37. PubMed ID: 25966823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database.
    Bartlett EK; Roses RE; Kelz RR; Drebin JA; Fraker DL; Karakousis GC
    Surgery; 2014 Aug; 156(2):298-304. PubMed ID: 24947651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of evidence-based therapy for resectable gastric cancer.
    Snyder RA; Penson DF; Ni S; Koyama T; Merchant NB
    J Surg Oncol; 2014 Sep; 110(3):285-90. PubMed ID: 24891231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
    Jack S; West MA; Raw D; Marwood S; Ambler G; Cope TM; Shrotri M; Sturgess RP; Calverley PM; Ottensmeier CH; Grocott MP
    Eur J Surg Oncol; 2014 Oct; 40(10):1313-20. PubMed ID: 24731268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
    Puig CA; Hoskin TL; Day CN; Habermann EB; Boughey JC
    Ann Surg Oncol; 2017 May; 24(5):1242-1250. PubMed ID: 28000076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
    Sun Z; Nussbaum DP; Speicher PJ; Czito BG; Tyler DS; Blazer DG
    J Surg Oncol; 2015 Jul; 112(1):46-50. PubMed ID: 26179329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes.
    Liu Y; Zhang KC; Huang XH; Xi HQ; Gao YH; Liang WQ; Wang XX; Chen L
    World J Gastroenterol; 2018 Jan; 24(2):257-265. PubMed ID: 29375211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.